David Shaw’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-50,000
Closed -$1.79M 4524
2013
Q4
$1.79M Sell
50,000
-20,000
-29% -$664K ﹤0.01% 2631
2013
Q3
$2.11M Buy
70,000
+50,000
+250% +$1.63M ﹤0.01% 2373
2013
Q2
$583K Buy
+20,000
New +$564K ﹤0.01% 3125

Other funds holding PBH

David Shaw's PBH Position: Q2 2026 in Review

David Shaw reduced its Prestige Consumer Healthcare (PBH) stake by 18% in Q2 2026, selling an estimated $3.46M and leaving 313,778 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1517.

David Shaw first reported a position in PBH in Q3 2013 and has held it in 35 quarters since. The position peaked at $33.6M in Q3 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • David Shaw held 313,778 shares of Prestige Consumer Healthcare worth $14.8M as of Q2 2026.
  • David Shaw sold 67,255 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.46M.
  • Prestige Consumer Healthcare made up 0.01% of David Shaw's portfolio in Q2 2026, its #1517 holding.
  • David Shaw first reported a position in Prestige Consumer Healthcare in Q3 2013 and has held it in 35 quarters since.
  • David Shaw's Prestige Consumer Healthcare position peaked at $33.6M in Q3 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.